Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ0K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $57,350
Award facts
- Contract value 100% obligated
- $57,350.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $57,350 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Mounjaro 5 mg/0.5 mL pens (0.5 mL). This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of January 16, 2026. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
Mounjaro (tirzepatide) is a diabetes management medication used to improve glycemic control in patients with type 2 diabetes. As a critical pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen leverages its extensive federal contract portfolio to supply essential medications and medical commodities to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The company's selection for this award demonstrates its established capability to meet federal procurement requirements for specialized pharmaceutical products across multiple therapeutic domains, supporting the Defense Health Agency and other government healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DR26FJJ0K?
SPE2DR26FJJ0K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26FJJ0K worth?
The government has obligated $57,350 on SPE2DR26FJJ0K.
Is contract SPE2DR26FJJ0K an order under another contract?
Yes. SPE2DR26FJJ0K is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ0K competed?
The extent of competition for SPE2DR26FJJ0K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award